Current Vascular Pharmacology
Title:Editorial: Your VISION Will Become Clear Only When You Look Into Your Heart
Volume: 14 Issue: 4
Author(s): Kosmas I. Paraskevas, Dimitri P. Mikhailidis and Gerard P. Stansby
Affiliation:
Export Options
About this article
Cite this article as:
I. Paraskevas Kosmas, P. Mikhailidis Dimitri and P. Stansby Gerard, Editorial: Your VISION Will Become Clear Only When You Look Into Your Heart, Current Vascular Pharmacology 2016; 14 (4) . https://dx.doi.org/10.2174/1570161114999160418121853
DOI https://dx.doi.org/10.2174/1570161114999160418121853 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Advancements in Arterial Stiffness: Novel Therapeutic Frontiers
Arterial stiffness, a hallmark of cardiovascular disease, poses significant challenges in contemporary healthcare. This thematic issue delves into the multifaceted landscape of arterial stiffness and explores cutting-edge therapeutic interventions aimed at mitigating its adverse effects. Within these pages, readers will find a comprehensive overview of the mechanisms underlying arterial stiffness, ...read more
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pediatric CKD and Cardivascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Methionine AminoPeptidase Type-2 Inhibitors Targeting Angiogenesis
Current Topics in Medicinal Chemistry Lipid Based Nanoparticles as Inherent Reversing Agents of Multidrug Resistance in Cancer
Current Pharmaceutical Design An Updated Review on <i>Betacoronavirus</i> Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery
Current Topics in Medicinal Chemistry Bioactive Molecules Used in Biomimetic Scaffolds: The Recent Progress in the Angiogenesis of Thick Tissue Engineering
Current Tissue Engineering (Discontinued) Children with Chronic Kidney Disease and Hypertension: Could Hypertension Footprints be Early Biomarkers?
Current Hypertension Reviews Thymosin β4 Protein Therapy for Cardiac Repair
Current Pharmaceutical Design A Giant Internal Iliac Artery Aneurysm with Arteriovenous Fistulization
Current Medical Imaging Biophysical Modeling and Associated Signal Modeling in Functional Magnetic Resonance Imaging
Neuroscience and Biomedical Engineering (Discontinued) HDL - Cholesterol: The New Target for Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Silent Cerebral Damage in Hypertension
Current Hypertension Reviews Ivabradine: A Current Overview
Current Clinical Pharmacology Cardiovascular Magnetic Resonance Imaging: State of the Art
Current Cardiology Reviews Mechanisms and Consequences of Protein Aggregation: The Role of Folding Intermediates
Current Protein & Peptide Science Mesenchymal Stem Cells: A Good Candidate for Restenosis Therapy?
Current Vascular Pharmacology Pharmacological Potential of Exercise and RAS Vasoactive Peptides for Prevention of Diseases
Current Protein & Peptide Science Aldose Reductase / Polyol Inhibitors for Diabetic Retinopathy
Current Pharmaceutical Biotechnology Sacubitril/Valsartan: A New Dawn has Begun! A Revisited Review
Current Cardiology Reviews Coronary Artery Ectasia-A Review of Current Literature
Current Cardiology Reviews Stearoyl-CoA Desaturase: A Vital Checkpoint in the Development and Progression of Obesity
Endocrine, Metabolic & Immune Disorders - Drug Targets